Ireland· IE-PA-PA2315/280/001

Linagliptin Accord 5 mg film-coated tablets

A linagliptin product containing linagliptin, registered in Ireland by Accord Healthcare Ireland Ltd.. The same ATC class is registered in 17 of our 19 countries.

ATC A10BH05

Checked against HPRA (Ireland) on September 28, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about linagliptinAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Linagliptin is registered in 17 of 19 countries.

Countries holding a registration under ATC A10BH05 (linagliptin), each read from that country’s own register.

This record: Ireland, from HPRA (Ireland)
9 of them publish a price we can compare per daily dose

Search linagliptin products by name

Linagliptin · ATC A10BH05

17 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Germany
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of linagliptin costs, country by country.

Normalised to the WHO defined daily dose (5 mg), so markets compare like for like.

2 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Linagliptin · price per daily dose (5 mg)

USD · FX 28 Sept 2026

IT Italy$2.52
CH Switzerland$2.05

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

HPRA (Ireland)

Active substance: Linagliptin
Manufacturer: Accord Healthcare Ireland Ltd.
Country: Ireland (IE)
ATC code: A10BH05
ATC class: Linagliptin
Defined daily dose: 5 mg, O
Reimbursed: Not published by this register
Source register: HPRA (Ireland)
Last checked: September 28, 2026

Packs & prices · 1

ie_pa_number
PA2315/280/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

373 interactions on record for linagliptin.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check linagliptin against other medicines How interaction checks work

Linagliptin · interactions on record

373 records

3 severe
330 moderate
40 minor

Most severe, free to view

GatifloxacinJ01MA16severe
SucralfateA02BX02moderate
ThiethylperazinA04AB03moderate
TriflupromazinA04AD06moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Linagliptin in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All linagliptin products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

Austria · Ilinpru, Liamell
Belgium · Linagliptin Eg, Linagliptin Eg (Eurogenerics) Nv
Bulgaria · Linagliptin Accord, Глунава
Cyprus · Glunava, Linagliptin Accord
Czechia · Glunava, Jeligo
Germany · Linagliptin Abdi
Denmark · Linagliptin "pharmapath", Linagliptin Accord
Estonia · Glunava, Linagliptin Accord
Spain · Donumid, Ilinpru
Finland · Linagliptin Accord, Linagliptin Advanz Pharma
France · Linagliptine Zentiva
United Kingdom (Northern Ireland) · Linagliptin, Linagliptin Altair Science
Greece · Bottiar, Drojarto
Croatia · Larida, Liglinra
Hungary · Ilinpru, Jeligo
Iceland · Linagliptin Krka, Linagliptin Stada
Italy · Linagliptin Abdi, Linagliptin Aurobindo
Liechtenstein · Trajenta
Lithuania · Bottiar, Jeligo
Luxembourg · Linagliptin Eg
Latvia · Linagliptin Accord, Linagliptin Olpha
Malta · Liamell, Linagliptin
Netherlands · Linagliptin Viatris, Linagliptin Vivanta
Norway · Linagliptin Accord, Linagliptin Krka
Poland · Jeligo, Larida
Portugal · Enanta, Larida
Romania · Jeligo, Linagliptin Medochemie
Sweden · Liglinra, Linagliptin Accord
Slovenia · Liglipex, Linagliptin Krka
Slovakia · Glunava, Ilinpru

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/fd21d252-0cef-4ad4-a5ca-1b507f4f9f40
GET /v1/drugs/fd21d252-0cef-4ad4-a5ca-1b507f4f9f40?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "routes": [
    "Oral use"
  ],
  "source": "hpra",
  "atc_all": [
    "A10BH05"
  ],
  "strength": null,
  "pa_number": "PA2315/280/001",
  "substances": [
    "Linagliptin"
  ],
  "legal_basis": "Generic application (Article 10(1) of Directive No 2001/83/EC)",
  "market_info": "Not marketed",
  "authorised_at": "30/01/2026",
  "dispensing_status": "Product subject to prescription which may be renewed (B)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

API reference MCP server Plans

See everything about linagliptin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console